AnaptysBio
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune an...
AnaptysBio Logo
About AnaptysBio
AnaptysBio, Inc. operates as a clinical stage biotechnology company. The Company manufactures and markets antibodies for cancer immunotherapy and inflammation. AnaptysBio has primary operations in the United States.
Address
10770 Wateridge Circle, Suite 210
San Diego, 92121-5801
United States
Year founded
2005
Number of employees
100-200
Report inaccurate data
Request an update to help us keep the brand up-to-date.
